Elevance Health Valuation

ELV Stock  USD 402.55  1.05  0.26%   
At this time, the firm appears to be undervalued. Elevance Health shows a prevailing Real Value of $504.74 per share. The current price of the firm is $402.55. Our model computes the value of Elevance Health from reviewing the firm fundamentals such as Profit Margin of 0.04 %, shares outstanding of 231.92 M, and Current Valuation of 112.64 B as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Elevance Health's valuation include:
Price Book
2.1327
Enterprise Value
112.6 B
Price Sales
0.5365
Forward PE
11.534
Trailing PE
14.6648
Undervalued
Today
402.55
Please note that Elevance Health's price fluctuation is very steady at this time. Calculation of the real value of Elevance Health is based on 3 months time horizon. Increasing Elevance Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Elevance stock is determined by what a typical buyer is willing to pay for full or partial control of Elevance Health. Since Elevance Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Elevance Stock. However, Elevance Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  402.55 Real  504.74 Target  570.0 Hype  400.56 Naive  386.22
The intrinsic value of Elevance Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Elevance Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
362.30
Downside
504.74
Real Value
506.61
Upside
Estimating the potential upside or downside of Elevance Health helps investors to forecast how Elevance stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Elevance Health more accurately as focusing exclusively on Elevance Health's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
8.253.808.28
Details
Hype
Prediction
LowEstimatedHigh
398.69400.56442.81
Details
Potential
Annual Dividend
LowForecastedHigh
4.484.574.67
Details
22 Analysts
Consensus
LowTarget PriceHigh
518.70570.00632.70
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Elevance Health's intrinsic value based on its ongoing forecasts of Elevance Health's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Elevance Health's closest peers.

Elevance Health Cash

3.29 Billion

Elevance Valuation Trend

Analysing the historical paterns of Elevance Health's enterprise value and its market capitalization is a good way to estimate and gauge the value of Elevance Health over time and is usually enough for investors to make rational market timing decisions.

Elevance Revenue by Product

Elevance Health Total Value Analysis

Elevance Health is currently expected to have company total value of 112.64 B with market capitalization of 93.36 B, debt of 25.12 B, and cash on hands of 7.39 B. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Elevance Health fundamentals before making security assessment based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
112.64 B
93.36 B
25.12 B
7.39 B

Elevance Health Investor Information

About 92.0% of the company shares are held by institutions such as insurance companies. The book value of Elevance Health was currently reported as 188.74. The company has Price/Earnings To Growth (PEG) ratio of 0.75. Elevance Health recorded earning per share (EPS) of 27.45. The entity last dividend was issued on the 5th of December 2024. The firm had 2:1 split on the 1st of June 2005. Based on the key indicators obtained from Elevance Health's historical financial statements, Elevance Health may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.
Current ValueLast YearChange From Last Year 10 Year Trend
Operating Profit Margin0.820.7818
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities4.3 B8.1 B
Way Down
Slightly volatile
Operating Income141.9 B135.1 B
Sufficiently Up
Slightly volatile

Elevance Health Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Elevance Health has an asset utilization ratio of 157.3 percent. This indicates that the Company is making $1.57 for each dollar of assets. An increasing asset utilization means that Elevance Health is more efficient with each dollar of assets it utilizes for everyday operations.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Elevance Health Ownership Allocation

Elevance Health holds a total of 231.92 Million outstanding shares. The majority of Elevance Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to obtain positions in Elevance Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Elevance Health. Please pay attention to any change in the institutional holdings of Elevance Health as this could imply that something significant has changed or is about to change at the company. Please note that on September 25, 2024, Representative William R Keating of US Congress acquired under $15k worth of Elevance Health's common stock.

Elevance Health Profitability Analysis

The company reported the last year's revenue of 171.34 B. Total Income to common stockholders was 5.99 B with profit before taxes, overhead, and interest of 40.11 B.

Elevance Health Past Distributions to stockholders

About Elevance Health Valuation

Our relative valuation model uses a comparative analysis of Elevance Health. We calculate exposure to Elevance Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Elevance Health's related companies.
Last ReportedProjected for Next Year
Gross Profit47 B56 B
Pretax Profit Margin 0.05  0.07 
Operating Profit Margin 0.78  0.82 
Net Profit Margin 0.03  0.03 
Gross Profit Margin 0.27  0.19 

Elevance Health Quarterly Retained Earnings

35.16 Billion

Elevance Health's stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Elevance Health's value is low or high relative to the company's performance and growth projections. Determining the market value of Elevance Health can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Elevance Health represents a small ownership stake in the entity. As a stockholder of Elevance, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Elevance Health Dividends Analysis For Valuation

Dividend Yield is likely to climb to 0.02 in 2024, whereas Dividends Paid is likely to drop slightly above 830.2 M in 2024. . At this time, Elevance Health's Retained Earnings are fairly stable compared to the past year. Earnings Yield is likely to climb to 0.06 in 2024, whereas Retained Earnings Total Equity is likely to drop slightly above 17.6 B in 2024.
Last ReportedProjected for Next Year
Dividends Paid1.4 B830.2 M
Dividend Yield 0.01  0.02 
Dividend Payout Ratio 0.23  0.16 
Dividend Paid And Capex Coverage Ratio 3.00  2.85 
There are various types of dividends Elevance Health can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Elevance shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Elevance Health directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Elevance pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Elevance Health by the value of the dividends paid out.

Elevance Health Growth Indicators

Investing in growth stocks can be very risky. If the company such as Elevance Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding237.4 M
Quarterly Earnings Growth Y O Y-0.2
Forward Price Earnings11.534

Elevance Health Current Valuation Indicators

Elevance Health's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Elevance Health's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Elevance Health, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Elevance Health's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Elevance Health's worth.

Additional Tools for Elevance Stock Analysis

When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.